Why promoter design is no longer just an expression checkbox, it’s the key to therapeutic endurance:
Why promoter design is no longer just an expression checkbox, it’s the key to therapeutic…
Einbeck, Germany; Amsterdam, The Netherlands December 5, 2024
KWS SAAT SE & Co. KGaA and Annogen B.V. today announced a partnership in which Annogen will use its FACE™ platform to functionally annotate non-coding variants that are of interest to KWS. FACE™ is an adaptation of Annogen’s SuRE™ screen that allows for the swift testing of non-coding variants in plant protoplasts to help identify potential gain-of-function and loss-of-function genome variants.
